Insider Analysis From BioForesight: Navigating the Life Sciences Silk Road Frontier
This article was originally published in PharmAsia News
Executive Summary
By Zhu Shen, Chief Executive Officer, BioForesight
You may also be interested in...
Barack Obama's Meeting With Chinese President Bodes Well For Pan-Pacific Pharma Partnerships, Says Analyst During Shanghai Conference
SHANGHAI - Despite the financial maelstrom that has lashed economies from the Americas to Asia, U.S. President Barack Obama's April 1 meeting with Chinese President Hu Jintao is ultimately likely to boost the pharmaceutical sector in each country and the potential for pan-Pacific partnerships, according to the chief executive officer of the San Diego-based consulting firm BioForesight
Barack Obama's Meeting With Chinese President Bodes Well For Pan-Pacific Pharma Partnerships, Says Analyst During Shanghai Conference
SHANGHAI - Despite the financial maelstrom that has lashed economies from the Americas to Asia, U.S. President Barack Obama's April 1 meeting with Chinese President Hu Jintao is ultimately likely to boost the pharmaceutical sector in each country and the potential for pan-Pacific partnerships, according to the chief executive officer of the San Diego-based consulting firm BioForesight
Sundia Meditech’s CEO On Driving Innovation In China’s Pharma Sector
China will be world’s second largest pharma market by 2020, CRO chief predicts.